NCT03535337

Brief Summary

The purpose of this study is to test an adaptive adherence intervention, which utilizes two mobile health (mHealth) intervention designs, in an effort to promote adherence to antiretroviral therapy (ART) and achieve and maintain viral load (VL) suppression in youth living with HIV (YLH) while increasing understanding of the context for wide-scale implementation of cell phone support (CPS) and text messaging support (SMS), with and without incentives.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P25-P50 for not_applicable hiv-infections

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 24, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

December 13, 2024

Completed
Last Updated

December 13, 2024

Status Verified

December 1, 2024

Enrollment Period

3.7 years

First QC Date

April 12, 2018

Results QC Date

May 30, 2023

Last Update Submit

December 10, 2024

Conditions

Keywords

Interventionsyouth living with HIVmHealthART adherenceadaptive interventioncell phonetext messaging

Outcome Measures

Primary Outcomes (3)

  • Undetectable Viral Load

    Percent of participants that have an undetectable HIV Viral Load.

    baseline, month 3, month 6, month 9, and month 12

  • Medication Adherence Rate - 7 Day

    Self reported percentage of medication taken in the past 7 days prior to assessment point. Medication adherence rates will be compared between CPS and SMS groups.

    baseline, month 3, month 6, month 9, and month 12

  • Medication Adherence - 30 Days

    Self reported percentage of medication taken in the past 30 days prior to assessment point. Medication adherence rates will be compared between CPS and SMS groups.

    baseline, month 3, month 6, month 9, and month 12

Study Arms (8)

CPS-Rsp-T

ACTIVE COMPARATOR

After 3 months of intervention, this group of CPS Rsp will receive 3 months of CPS-T intervention followed by SC.

Behavioral: CPS

CPS-Rsp-SC

ACTIVE COMPARATOR

After 3 months of intervention, this group of CPS Rsp's intervention will discontinue and they'll receive SC only

Behavioral: CPS

CPS-NRsp-I

ACTIVE COMPARATOR

After 3 months of intervention, this group of CPS NRsp will receive 3 months of CPS-I followed by 3 months of CPS-T and 3 months of SC.

Behavioral: CPS

CPS-NRsp-SMS-I

ACTIVE COMPARATOR

After 3 months of intervention, this group of CPS NRsp will receive 3 months of SMS-I followed by 3 months of SMS-T and 3 months of SC

Behavioral: CPS

SMS-Rsp-T

ACTIVE COMPARATOR

After 3 months of intervention, this group of SMS Rsp will receive 3 months of SMS tapered (SMS-T) intervention followed by SC.

Behavioral: SMS

SMS-Rsp-SC

ACTIVE COMPARATOR

After 3 months of intervention, this group of SMS Rsp, intervention will discontinue and they'll receive SC only

Behavioral: SMS

SMS-NRsp-CPS-I

ACTIVE COMPARATOR

After 3 months of intervention, this group of SMS NRsp will receive 3 months of CPS-I followed by 3 months CPS-T and 3 months SC

Behavioral: SMS

SMS-NRsp-I

ACTIVE COMPARATOR

After 3 months of intervention, this group of SMS NRsp will receive 3 months of SMS-I followed by 3 months of SMS-T and 3 months of SC

Behavioral: SMS

Interventions

CPSBEHAVIORAL

Assessment of participant's medication adherence and barrier problem solving via phone conversation

CPS-NRsp-ICPS-NRsp-SMS-ICPS-Rsp-SCCPS-Rsp-T
SMSBEHAVIORAL

Participants will receive a text message, which will be an electronic reminder regarding medication adherence. Participants will then text back a confirmatory response.

SMS-NRsp-CPS-ISMS-NRsp-ISMS-Rsp-SCSMS-Rsp-T

Eligibility Criteria

Age15 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • HIV diagnosis
  • Viral load ≥ 200 copies/mL within 3 months prior to enrollment or self-reported adherence ≤ 80%
  • ART medication regimen prescribed minimum of 3 months prior to eligibility VL or self-reported adherence
  • Sole owner of device capable of sending/receiving calls and text messages
  • Willingness to permit research team to communicate with their HIV care provider team

You may not qualify if:

  • Mental, physical, or emotional capacity prevents completion of protocol as written
  • Inability to understand written/spoken English
  • Concurrent participant in any adherence behavioral research intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The City University of New York

New York, New York, 10018, United States

Location

Related Publications (1)

  • Belzer ME, MacDonell KK, Ghosh S, Naar S, McAvoy-Banerjea J, Gurung S, Cain D, Fan CA, Parsons JT. Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Message and Cell Phone Support With and Without Incentives: Protocol for a Sequential Multiple Assignment Randomized Trial (SMART). JMIR Res Protoc. 2018 Dec 20;7(12):e11183. doi: 10.2196/11183.

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Sylvie Naar, PhD; Distinguished Endowed Professor
Organization
Florida State University

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: Multiple Assignment Randomized Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 12, 2018

First Posted

May 24, 2018

Study Start

September 1, 2018

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

December 13, 2024

Results First Posted

December 13, 2024

Record last verified: 2024-12

Locations